Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics.
about
Improved COBAS TaqMan Hepatitis C Virus Test (Version 2.0) for Use with the High Pure System: Enhanced Genotype Inclusivity and Performance Characteristics in a Multisite StudyUpdate on hepatitis B and C virus diagnosisCurrent molecular methods for the detection of hepatitis C virus in high risk group population: A systematic reviewDynamic range of hepatitis C virus RNA quantification with the Cobas Ampliprep-Cobas Amplicor HCV Monitor v2.0 assay.Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatPerformance characteristics of the COBAS Amplicor Hepatitis C Virus (HCV) Monitor, Version 2.0, International Unit assay and the National Genetics Institute HCV Superquant assayPerformance of the New Bayer VERSANT HCV RNA 3.0 assay for quantitation of hepatitis C virus RNA in plasma and serum: conversion to international units and comparison with the Roche COBAS Amplicor HCV Monitor, Version 2.0, assay.Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA.Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay.Quantitative detection of hepatitis C virus (HCV) RNA in saliva and gingival crevicular fluid of HCV-infected patients.Rapid Genotyping of Hepatitis C Virus by Primer-Specific Extension AnalysisEvaluation of the invader assay for genotyping hepatitis C virusComparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5Performance Evaluation of the VERSANT HCV RNA Qualitative Assay by Using Transcription-Mediated AmplificationComparative Evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR Version 2.0 Assays for Quantification of Hepatitis C Virus RNA in SerumClinical Evaluation of Two Methods for Genotyping Hepatitis C Virus Based on Analysis of the 5' Noncoding RegionLaboratory Assays for Diagnosis and Management of Hepatitis C Virus InfectionHepatitis C virus RNA quantitation and degradation studies in whole blood samples in vitroIncreased Sensitivity of the Roche COBAS AMPLICOR HCV Test, Version 2.0, Using Modified Extraction TechniquesComparison of Performance Characteristics of Three Real-Time Reverse Transcription-PCR Test Systems for Detection and Quantification of Hepatitis C VirusA Novel Diagnostic Target in the Hepatitis C Virus GenomeAbbott RealTime Hepatitis C Virus (HCV) and Roche Cobas AmpliPrep/Cobas TaqMan HCV Assays for Prediction of Sustained Virological Response to Pegylated Interferon and Ribavirin in Chronic Hepatitis C PatientsPrion protein expression and processing in human mononuclear cells: the impact of the codon 129 prion gene polymorphism.Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatmentAssessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a.Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus testsDental problems delaying the initiation of interferon therapy for HCV-infected patients.A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: association study with mutations in the core and NS5A region of hepatitis C virus.Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseasesAssociation of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection.Strengths and limitations of commercial tests for hepatitis C virus RNA quantificationPerformance of the novel Qiagen artus QS-RGQ viral load assays compared to that of the Abbott RealTime system with genetically diversified HIV and hepatitis C Virus plasma specimensEffect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study.Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent.Diagnosing norovirus-associated infectious intestinal disease using viral loadEvaluation of the core antigen assay as a second-line supplemental test for diagnosis of active hepatitis C virus infection.Is HCV core antigen a reliable marker of viral load? An evaluation of HCV core antigen automated immunoassay.Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.Verification of an assay for quantification of hepatitis C virus RNA by use of an analyte-specific reagent and two different extraction methodsSuccessful Treatment of Hepatitis C Virus-associated Oral Lichen Planus by Interferon-free Therapy with Direct-acting Antivirals
P2860
Q24289102-68DCB518-A76E-48F9-B9E4-832EDB477988Q26777048-BF709081-F3FD-4C45-9C1F-5FD30DCB5199Q26851978-7D85ABC9-8562-4926-8450-2C7392285F42Q27469461-8AB86095-F360-49C9-8B76-1A1C01D94930Q27469977-EF4B08C5-13EE-4811-8EFD-B29093A8BF40Q27471191-F5AE73DC-D757-4D70-A774-3FA7C68AD9C5Q27471213-F8CF485F-A4F0-4A39-B26C-30799C7E8CACQ27471239-799DB58D-0BDF-4DC9-851A-83864546925DQ27471406-509DBB42-D975-4660-9987-A5204992A5B4Q27472050-B0C55629-71D1-4818-811C-DDC8E4AF3918Q27472598-1DDD6577-B459-47D9-B6FC-7CCFD5CF5878Q27473033-B57A52A9-5070-442C-8F32-FB1345E17B5DQ27473038-13919A65-0BB0-473C-8AD9-4892348A4922Q27473324-626F5A1C-5B70-4199-942E-71A21E492618Q27473432-9D95A1AA-E97D-42D4-9D70-0C20810C66D2Q27473463-90F66928-0CFD-47AD-9159-FE01B136B51BQ27473492-95CE5C28-DF55-4152-8C16-06F3D9DA86D3Q27478334-10D96F31-A0A7-4761-9A22-5010F06F0809Q27478391-67C7109B-23F4-4299-8ED0-03CB7063C85EQ27481004-C0CCAE12-66C9-4D5D-A47B-9E87BBFA1309Q27487878-37BEF6B0-84F7-4618-A148-2B65B10C8138Q27487942-52799216-9164-47AF-B7EC-1ACB4AA41BABQ33460414-6585F96A-4BE5-4E56-B2DB-513FAD3C156DQ33557770-6BAF6DBE-A101-4C0A-AB1A-BCAF87FF6319Q33973127-3F3BF925-C038-4E3C-9B0E-3884400681D9Q33973999-9A480D31-0933-4C56-9F5E-B4B13B5585E4Q34104997-BC5C9B02-98B1-4FA8-8E27-2A1F5D07BA76Q34226904-4EDEFFC1-F640-470C-AB69-B39D6D84D648Q34466029-06BE51BC-89C5-418E-BB95-1F08007BF864Q35085706-7B99A34B-83E5-4A29-BDDE-CD283DB41C2AQ35551304-45673023-0CFE-4D92-A68C-32A7DFA0A554Q36022867-95EDDBA8-76CB-4960-97F6-05F40E2C953BQ36535642-9DE50440-58A4-472C-814B-2B5F53D4E513Q37156650-DFDBCDE9-DFB5-43BA-A4B1-80F532F8AE00Q37233578-6945A56A-B200-431B-AC67-0060926DACCDQ37511219-5BA36104-849C-4BFA-9A7F-9BCDD9047827Q37649327-9B99625A-0FA6-48E9-9722-65B307F5DAD8Q39465790-4F3FF0BA-F60A-4F51-829F-730F395D75C1Q39486678-74A924EC-B4FF-487D-8CF7-38291D3A5682Q40621942-C5D733AB-F654-44DE-B3C9-BA3C87AFC263
P2860
Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Improved version 2.0 qualitati ...... d performance characteristics.
@ast
Improved version 2.0 qualitati ...... d performance characteristics.
@en
type
label
Improved version 2.0 qualitati ...... d performance characteristics.
@ast
Improved version 2.0 qualitati ...... d performance characteristics.
@en
prefLabel
Improved version 2.0 qualitati ...... d performance characteristics.
@ast
Improved version 2.0 qualitati ...... d performance characteristics.
@en
P2093
P2860
P1476
Improved version 2.0 qualitati ...... d performance characteristics.
@en
P2093
K Gutekunst
M Rosenstraus
P2860
P304
P407
P577
2000-11-01T00:00:00Z